Quote:
Originally Posted by jfman
I suspect once adequate supplies of Pfizer are sourced to booster JCVI groups 1-9 and 12-15 year olds suddenly the advice will change. Entertainingly the current advice is for a single dose of Pfizer for 16 and 17 year olds - nothing about timing of (or even if there will be!) second doses. But it’s definitely definitely not a supply issue.
|
The evidence is that a single Pfizer dose is very effective in this age group, and that a second dose presents a risk of complications (enlarged heart muscle being the principal concern). As always it’s a matter of balancing risk and reward.
You’re starting to sound a bit deranged though. Maybe go out for a walk in the fresh air?